Buy Corvus Pharmaceuticals Stock | CRVS Stock Price & Latest News | Public
CRVS

Corvus Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About CRVS

    Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The company focuses on disabling cancer’s ability to subvert immune attack by inhibiting adenosine in the tumor micr...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.29
    -0.44
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.31

    Actual EPS
    Q4 2020

    Stats

    Market Cap$110,56M
    Volume1,4k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$6.88
    1 Year Low$1.01
    Open$3.92
    High$3.93
    Low$3.89

    Buy any stock with any amount of money.

    Download the App
    Download the app